🇺🇸 FDA
Patent

US 9730993

Engineered anthrax lethal toxin for targeted delivery

granted A61KA61K39/07A61K39/104

Quick answer

US patent 9730993 (Engineered anthrax lethal toxin for targeted delivery) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K39/07, A61K39/104, A61K47/6415, A61K47/66